Influence Mechanism and Imaging Effect of Liujunzi Decoction Combined with Network Pharmacology in Intervention of Breast Cancer
Objective To reveal the potential molecular mechanism of Liujunzi Decoction (LD) for Breast Cancer (BC) intervention built on network pharmacology, verify its clinical efficacy through imaging evaluation, and explore the response difference of different molecular types of BC to LD. Methods: The active ingredients and targets of LD were screened through the TCMSP; Integrating GeneCards, OMIM, and other databases, BC related targets were gained; The network of "Liujunzi Decoction - Components - Target Protein - Breast Cancer" was constructed, and the enrichment analysis of gene ontology/Kyoto gene and genome encyclopedia was carried out. AutoDock was used to verify the binding activity between core components and key targets; An interactive analysis platform based on gene expression levels and Kaplan-Meier Plotter was used to analyze prognostic gene expression. 500 BC cases were included. The consistency, sensitivity, and specificity of the therapeutic effect of LD after intervention were evaluated by dynamic enhanced MRI scanning. Results: LD and BC had several common targets, including proto-oncogene activator protein, cell tumor antigen p53, mitogen-activated protein kinase 3, etc. The results of gene ontology analysis demonstrated that biological process items mainly include RNA-pII-PTR, PRoCP, and angiogenesis; The cellular components mainly included dendrites, nuclei, cytoplasm, etc. The molecular functions mainly included protein binding, transcription factor binding, ubiquitin protein ligase binding, etc. The Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis showed that the cancer pathway had the highest degree of gene enrichment, at 58. In the imaging evaluation results, after intervention with LD, the consistency of MRI detection was high at 83.0%, but the specificity was low at 28.4%. The intervention response of BC patients with different molecular types to LD was significantly different. HR+/HER2 subtype MRI had the highest diagnostic consistency, the highest positive predictive value, and the lowest negative predictive value. Conclusion: This study confirms that LD can intervene in BC through multi-component, multi-target, and multi-channel synergistic action, and imaging technology can directly reflect its therapeutic effect.
Authors
- Yanshu Jia (ORCID: https://orcid.org/0009-0007-8302-8728)
- Vijay Kotra (ORCID: https://orcid.org/0000-0002-2043-4928)
- Yingji Li
Institutions
- Quest International University Perak (MY)
- Yunnan University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- WSEAS TRANSACTIONS ON BIOLOGY AND BIOMEDICINE
- Published
- 2026-11-20
- DOI
- https://doi.org/10.37394/23208.2026.23.35
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00